About
Technology
Issues
FAQ
Links
Official Page
Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.